Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A phase 2 study with tafasitamab and zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – taza CLL

Georgios Pongas, Matthew Mei, Lu Chen, Geoffrey Shouse, Rachel Bellsmith, Ivana Melgar, Steven Rosen, Tanya Siddiqi, Alexey Danilov

Blood (2025) 146 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2025-2134

Published: 2025

Journal Articles

A Phase 2 trial of AI-BEL (AZT/Interferon-α plus Belinostat) for HTLV-1 related adult T-cell leukemia-lymphoma: Final safety and efficacy Results

Georgios Pongas, Isildinha Reis, Ngoc Toomey, Catalina Amador, Yi Zhou, Erik Guillen, Gregoire Lauvau, B. Hilda Ye, Jennifer Chapman, Juan Carlos Ramos

Blood (2025) 146 (Supplement 1): 563.

https://doi.org/10.1182/blood-2025-563

Published: 2025

Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Blood (2025) 146 (Supplement 1): 5351.

https://doi.org/10.1182/blood-2025-5351

Published: 2025

Journal Articles

Mosunetuzumab and polatuzumab combined with axicabtagene ciloleucel induce high complete response rates at day+90 in Relapsed/Refractory large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 1009.

https://doi.org/10.1182/blood-2025-1009

Published: 2025

Journal Articles

Characterizing the biological function FOXO3 and its role as a predictive biomarker in HTLV-1 related adult T-cell leukemia-lymphoma

Georgios Pongas, Ngoc Toomey, Juan Carlos Ramos

Blood (2025) 146 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2025-3546

Published: 2025

Journal Articles

Patterns of care in second line management of nodal peripheral T-cell lymphoma from the lymphoma epidemiology of outcomes (LEO) and molecular epidemiology resource (MER) prospective cohort Study

Blood (2025) 146 (Supplement 1): 3635.

https://doi.org/10.1182/blood-2025-3635

Published: 2025

Journal Articles

Shorter diagnosis to treatment interval is associated with poor prognosis in patients with peripheral T-cell lymphoma: Analysis from the LEO and MER cohorts

Blood (2025) 146 (Supplement 1): 5439.

https://doi.org/10.1182/blood-2025-5439

Published: 2025

Journal Articles

Diagnostic and therapeutic patterns in cutaneous T-cell lymphomas (CTCL): Real-world data from the lymphoma epidemiology outcome-molecular epidemiology resource (LEO-MER) prospective cohort study.

Muhammad Saad Hamid, Ashley McCook-Veal, Jeffrey Switchenko, Neha Mehta-Shah, Neha Akkad, Luis Malpica, Danielle Wallace, Evelyn Orlando, Jia Ruan, Brooj Abro, Melissa Larson, James Cerhan, Christopher Flowers, Georgios Pongas, Eric Mou, N. Nora Bennani, Pamela Allen

Blood (2025) 146 (Supplement 1): 1870.

https://doi.org/10.1182/blood-2025-1870

Published: 2025

Journal Articles

Feasibility and preliminary efficacy of a Mediterranean diet and home-based exercise intervention during chemotherapy for lymphoma survivors: The life-l study

Melissa Lopez-Pentecost, Tracy Crane, Akina Natori, Juan Alderuccio, Alvaro Alencar, Michele Stanchina, Georgios Pongas, Asaad Trabolsi, Jonathan Schatz, Ashley Rose, David Lessen, Joseph Rosenblatt, Izidore S. Lossos, Juan Carlos Ramos, Russ Kuker, Craig Moskowitz

Blood (2025) 146 (Supplement 1): 4547.

https://doi.org/10.1182/blood-2025-4547

Published: 2025

Journal Articles

Safety and Efficacy of AZT-Interferon-α with Belinostat (AI-BEL) for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma

Georgios Pongas, Ngoc Toomey, Isildinha Reis, Jennifer R. Chapman-Fredricks, Yi Zhou, Erik Guillen, Eric Liu, Gregoire Lauvau, B. Hilda Ye, Juan Carlos Ramos

Blood (2024) 144 (Supplement 1): 1720.

https://doi.org/10.1182/blood-2024-209155

Published: 2024

Journal Articles

High Complete Responses with Combination of Platinum-Based Regimen with BTK Inhibitors in Richter's Syndrome: University of Miami - Case Series

Georgios Pongas, Maryam Alasfour, Deborah Soong, Juan Pablo Alderuccio, Izidore S. Lossos

Blood (2024) 144 (Supplement 1): 6797.

https://doi.org/10.1182/blood-2024-211550

Published: 2024

Journal Articles

Polatuzumab-Vedotin Plus Bendamustine and Rituximab for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis

Andres Bravo-Gonzalez, Maria Paula Alviar-Ortiz, Elsa Vasquez-Trespalacios, Georgios Pongas

Blood (2024) 144 (Supplement 1): 4463.

https://doi.org/10.1182/blood-2024-193642

Published: 2024

Journal Articles

Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma

Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H. Schatz, Russ Kuker, David Sicre, Georgios Pongas, Isildinha M. Reis, Jay Y. Spiegel, Laura Medina Andara, Lazaros J. Lekakis, Joseph S. Gyedu, Jose Sandoval-Sus, Amer M. Beitinjaneh, Michele D. Stanchina, Asaad Trabolsi, Izidore S. Lossos, Joseph D. Rosenblatt, David S. Lessen, Craig H. Moskowitz

Blood (2024) 144 (Supplement 1): 337.

https://doi.org/10.1182/blood-2024-199093

Published: 2024

Journal Articles

Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Blood (2023) 142 (Supplement 1): 3045.

https://doi.org/10.1182/blood-2023-187237

Published: 2023

Journal Articles

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood (2023) 142 (Supplement 1): 5149.

https://doi.org/10.1182/blood-2023-173992

Published: 2023

Journal Articles

Safety and Efficacy of Belinostat Trial with Zidovudine Plus Interferon for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma: Interim Results

Georgios Pongas, Ngoc L Toomey, Isildinha M. Reis, Krishna V. Komanduri, Jennifer R Chapman-Fredricks, Juan Carlos Ramos

Blood (2022) 140 (Supplement 1): 9448–9449.

https://doi.org/10.1182/blood-2022-167888

Published: 2022

Journal Articles

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Blood (2022) 140 (Supplement 1): 9286–9288.

https://doi.org/10.1182/blood-2022-160206

Published: 2022

Journal Articles

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138434

Published: 2020

Journal Articles

Sea-blue–colored histiocytes associated with bone marrow granulomas

Georgios Pongas

Blood (2013) 122 (4): 475.

https://doi.org/10.1182/blood-2013-02-482810

Published: 2013

Journal Articles

Anti-Platelet Factor 4/Heparin Antibodies in Patients with Gram Negative Bacteremia

Georgios Pongas, MD, Swapan Dasgupta, PhD, Perumal Thiagarajan, MD

Blood (2012) 120 (21): 3391.

https://doi.org/10.1182/blood.V120.21.3391.3391

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A phase 2 study with tafasitamab and zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – taza CLL

A Phase 2 trial of AI-BEL (AZT/Interferon-α plus Belinostat) for HTLV-1 related adult T-cell leukemia-lymphoma: Final safety and efficacy Results

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Mosunetuzumab and polatuzumab combined with axicabtagene ciloleucel induce high complete response rates at day+90 in Relapsed/Refractory large B-cell lymphoma

Characterizing the biological function FOXO3 and its role as a predictive biomarker in HTLV-1 related adult T-cell leukemia-lymphoma

Patterns of care in second line management of nodal peripheral T-cell lymphoma from the lymphoma epidemiology of outcomes (LEO) and molecular epidemiology resource (MER) prospective cohort Study

Shorter diagnosis to treatment interval is associated with poor prognosis in patients with peripheral T-cell lymphoma: Analysis from the LEO and MER cohorts

Diagnostic and therapeutic patterns in cutaneous T-cell lymphomas (CTCL): Real-world data from the lymphoma epidemiology outcome-molecular epidemiology resource (LEO-MER) prospective cohort study.

Feasibility and preliminary efficacy of a Mediterranean diet and home-based exercise intervention during chemotherapy for lymphoma survivors: The life-l study

Safety and Efficacy of AZT-Interferon-α with Belinostat (AI-BEL) for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma

High Complete Responses with Combination of Platinum-Based Regimen with BTK Inhibitors in Richter's Syndrome: University of Miami - Case Series

Polatuzumab-Vedotin Plus Bendamustine and Rituximab for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis

Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma

Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Safety and Efficacy of Belinostat Trial with Zidovudine Plus Interferon for HTLV-1 Related Adult T-Cell Leukemia-Lymphoma: Interim Results

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Sea-blue–colored histiocytes associated with bone marrow granulomas

Anti-Platelet Factor 4/Heparin Antibodies in Patients with Gram Negative Bacteremia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only